MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-06-0091599
Triokind Pharmaceuticals Private Limited
Triokind Pharmaceuticals Private Limited - business services in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹77.19 Lakh
▲ 11% YoY
Net loss · FY 2025
₹19,338
Net margin -0.3%
EBITDA · FY 2025
₹61,391
EBITDA margin 0.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Triokind Pharmaceuticals Private Limited
Data last updated:
Triokind Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 17 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2019PTC344581. Its GSTIN is 07AAHCT1283A1ZN (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pawan Narayan and Deepak Narayan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H. No – 44 Near Barat Ghar, Punarvas Colony Pocket – 4 Sector – A/6, Delhi, India – 110040.
As per the financials filed for FY 2025, the company reported a revenue of ₹77.19 Lakh, a growth of 11% compared to the previous year. For the same year it recorded a net loss of ₹19,338 (net margin -0.3%) and EBITDA of ₹61,391 (EBITDA margin 0.8%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 69% over five years.
Triokind Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0091599). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999DL2019PTC344581
Registration Number 344581
Incorporation Date 17 January 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-06-0091599
Key People
Pawan Narayan Director Deepak Narayan Director Recognitions & Rankings of Triokind Pharmaceuticals
Contact details
Triokind Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressH. No – 44 Near Barat Ghar, Punarvas Colony Pocket – 4 Sector – A/6, Delhi, India – 110040
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Triokind Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Triokind Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Triokind Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Triokind Pharmaceuticals Private Limited, buy the company report.
Financials of Triokind Pharmaceuticals Private Limited
FY 2025 filings availableTriokind Pharmaceuticals Private Limited reported revenue of ₹77.19 Lakh (up 11% YoY) for FY 2025.
Revenue · FY 2025
₹77.19 Lakh ▲ 11%
Net loss · FY 2025
₹19,338 margin -0.3%
EBITDA · FY 2025
₹61,391 margin 0.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▼ 1%
5 years · compounded
▲ 69%
EBITDA CAGR growth
1 year
▼ 22%
3 years · compounded
▲ 66%
5 years · compounded
▲ 37%
Revenue has grown at a compounded annual rate (CAGR) of 69% over five years, including 11% growth in the latest year. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹61,391 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹19,338 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | ||||
| Net Profit Margin | -0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Triokind Pharmaceuticals Private Limited, buy the company report.
Board of directors of Triokind Pharmaceuticals Private Limited
Triokind Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pawan Narayan | Director | 17 Jan 2019 | 7 Years 9 Months | Current |
| Deepak Narayan | Director | 17 Jan 2019 | 7 Years 9 Months | Current |
Peer comparison
Triokind Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Inara India Pharmaceuticals Private Limited | ₹77.65 Lakh (FY 2022) | 0.0% | Kolkata, West Bengal, India | |||
| Medishine Pharmaceuticals Private Limited | ₹77.61 Lakh (FY 2021) | 200.0% | Guwahati, Assam, India | |||
| Victoris Pharmaceuticals Private Limited | ₹77.29 Lakh (FY 2024) | 49.0% | Guwahati, Assam, India | |||
| Agnus Pharmaceuticals Private Limited | ₹77.22 Lakh (FY 2024) | -6.0% | Kozhikode, Kerala, India | |||
| Triokind Pharmaceuticals Private Limitedthis company | ₹77.19 Lakh (FY 2025) | -₹19,338 | -0.3% | 11.0% | Delhi, India | |
| Vasphar Pharmaceuticals Private Limited | ₹76.88 Lakh (FY 2025) | -17.0% | Kaithal, Haryana, India | |||
| Zwitt Pharmaceuticals Private Limited | ₹76.81 Lakh (FY 2025) | 141.0% | Ahmedabad, Gujarat, India | |||
| Salsburg Pharmaceuticals Private Limited | ₹76.8 Lakh (FY 2025) | 9.0% | New Delhi, Delhi, India |
To see the full peer comparison of Triokind Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Triokind Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Triokind Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Triokind Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAHCT1283A1ZN | Delhi | Active | 11 Apr 2019 |
To see the full GST registrations and return filing status of Triokind Pharmaceuticals Private Limited, buy the company report.
Recent activity
Triokind Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Deepak Narayan was appointed as Director on 17 Jan 2019.
AGM
Triokind Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Triokind Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Appointed
Deepak Narayan was appointed as Director.
Appointed
Pawan Narayan was appointed as Director.
Incorporation
17 Jan 2019
Triokind Pharmaceuticals Private Limited was registered on 17 Jan 2019 with Roc Delhi Ii & aged 7 years 9 months as per MCA records.
Frequently asked questions
Triokind Pharmaceuticals is an active private limited company based in Delhi, India. The company works in other services, within the business services industry. It was incorporated on 17 January 2019 (7+ years old) and is registered under CIN U74999DL2019PTC344581.
Triokind Pharmaceuticals has 2 current directors:
- Pawan Narayan - Director
- Deepak Narayan - Director
The latest financial statements of Triokind Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Triokind Pharmaceuticals is 07AAHCT1283A1ZN, registered in Delhi.
The CIN (Corporate Identification Number) of Triokind Pharmaceuticals is U74999DL2019PTC344581. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Triokind Pharmaceuticals was incorporated on 17 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Triokind Pharmaceuticals by revenue are Inara India Pharmaceuticals Private Limited, Medishine Pharmaceuticals Private Limited, Victoris Pharmaceuticals Private Limited, Agnus Pharmaceuticals Private Limited, Vasphar Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Deepak Narayan was appointed as Director on 17 Jan 2019. Pawan Narayan was appointed as Director on 17 Jan 2019.
Yes, Triokind Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-06-0091599).
The registered office of Triokind Pharmaceuticals is at H. No – 44 Near Barat Ghar, Punarvas Colony Pocket – 4 Sector – A6, Delhi, India – 110040.
Triokind Pharmaceuticals operates in the business services industry, in the other services segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages